Results 161 to 170 of about 19,280 (221)

Use of Terlipressin in AKI Associated with Hepatorenal Syndrome: CON. [PDF]

Kidney360
Willows J, Hiremath S.
europepmc   +1 more source

Human orthotopic liver transplantation: surgical aspects in 393 consecutive grafts. [PDF]

, 1988
Gordon, RD, Iwatsuki, S, Lerut, JP, Starzl, TE   +3 more
core  

Defining Renal Recovery in Patients With Hepatorenal Syndrome-Acute Kidney Injury: Experience From North American Studies. [PDF]

JGH Open
Mujtaba MA, Elsiesy H, Faiz S, Hussain SA, Gamilla-Crudo AKN, Karim A, Khan MI, Khattak MW, Zafar Z, Kueht M, Jamil K.   +10 more
europepmc   +1 more source

Readmission Rate, Predictors, Outcomes, and Burden of Readmission of Hepatorenal Syndrome in the United States: A Nationwide Analysis. [PDF]

JGH Open
Sohail A, Chaudhary AJ, Bhinder MM, Zahid K, Brown K.   +4 more
europepmc   +1 more source

Development and validation of a risk prediction model for hepatorenal syndrome in hepatic failure patients based on glucose-6-phosphate dehydrogenase and hepatic and renal function biochemical parameters. [PDF]

J Med Biochem
Liu H, Lan Y, Zhang K, Wang T, Mao D, Wang M.   +5 more
europepmc   +1 more source

The relationship between mean arterial pressure and terlipressin in hepatorenal syndrome-acute kidney injury reversal: A post hoc analysis. [PDF]

Hepatology
Cullaro G, Allegretti AS, Patidar KR, Patidar KR, Jamil K, Velez JCQ.   +5 more
europepmc   +1 more source

Use of Terlipressin in AKI Associated with Hepatorenal Syndrome: COMMENTARY. [PDF]

Kidney360
Allegretti AS.
europepmc   +1 more source

Protective effect of long-chain polyunsaturated fatty acids on hepatorenal syndrome in rats. [PDF]

World J Nephrol
Duailibe JBB, Viau CM, Saffi J, Fernandes SA, Porawski M.   +4 more
europepmc   +1 more source

Comparison of hepatorenal syndrome incidence and outcomes using previous and current diagnostic criteria in cirrhotic patients. [PDF]

Hepatol Forum
Akbas MM, Uzunlulu M, Torun C, Bahadir O.   +3 more
europepmc   +1 more source